ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Novacap, a French specialty and pharmaceutical chemicals company, will acquire CU Chemie Uetikon, which provides custom synthesis of drug intermediates and active pharmaceutical ingredients from a plant in Lahr, Germany. The company, with 135 employees, had sales of $45 million last year. “The acquisition of Uetikon fits perfectly into our strategy to reinforce our position in pharmaceuticals and health markets,” says Novacap CEO Pierre Luzeau. Novacap was formed in 2003 through the acquisition of a Rhodia business.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter